|Articles|June 1, 2006

PHT Corporation

PHT company profile

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content

© Ezume Images - © Ezume Images - stock.adobe.com

Gilead’s Single-Tablet Bictegravi/Lenacapavir Regimen Shows Positive Phase III ARTISTRY-1 Results in Virologically Suppressed Adults with HIV

ByAndy Studna, Senior Editor

November 13th 2025

© tippapatt - © tippapatt - stock.adobe.com

Advarra and IgniteData Partner to Streamline eSource-to-EDC Data Transfer

ByAndy Studna, Senior Editor

November 13th 2025

Improving Site Satisfaction Through Better Technology and Collaboration

ByAndy Studna, Senior Editor

November 13th 2025

© photon_photo - © photon_photo - stock.adobe.com

Getting Clinical Outsourcing Right

ByHenry Galio

November 12th 2025

Alkermes’ Alixorexton Shows Positive Phase II Results in Narcolepsy Type 2

ByAndy Studna, Senior Editor

November 12th 2025

PHT Corporation

Newsletter

Related Content

Gilead’s Single-Tablet Bictegravi/Lenacapavir Regimen Shows Positive Phase III ARTISTRY-1 Results in Virologically Suppressed Adults with HIV

Advarra and IgniteData Partner to Streamline eSource-to-EDC Data Transfer

Improving Site Satisfaction Through Better Technology and Collaboration

Getting Clinical Outsourcing Right

Alkermes’ Alixorexton Shows Positive Phase II Results in Narcolepsy Type 2

Trending on Applied Clinical Trials Online

Advarra and IgniteData Partner to Streamline eSource-to-EDC Data Transfer

Improving Site Satisfaction Through Better Technology and Collaboration

Getting Clinical Outsourcing Right

Modernizing Recruitment with Data, HCP Networks, and Last Mile Support

ACT Brief: AI Decision-Making, Sponsor Oversight Trends, and HHS Label Changes